Catalyst Wire Dossier Catalyst Wire Dossier

Steovess/Binosto

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Steovess/Binosto, covering 2024-12-13 to 2024-12-13. Get the full timeline:

Most recent: Clinical Trial Update: The Use of Steovess/Binosto After Denosumab Discontinuation to Prevent Increase in Bone Turnover [Phase 2]

See pricing